Earlier studies have reported that CTGF and Nov promoted tumorigenesis of PCa (Maillard et al, 2001; Yang et al, 2005), whereas the expression of Cyr61 was downregulated in PCa (Pilarsky et al, 1998). The gene discussed is CCN2; the disease is posterior cortical atrophy.